Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Cordran (flurandrenolide, USP) Lotion

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – July 2011

 

Summary View

PRECAUTIONS

General
  • Pediatric patients may absorb proportionately larger amounts.....
Information for Patients
  • 2. Do not use Cordran Lotion on the face, underarms, or groin areas unless directed by your physician

ADVERSE REACTIONS

Postmarketing Adverse Reactions
  • The following adverse reactions have been identified during post approval use of flurandrenolide lotion. Because these reactions .....
-
-